Bone drugs may help prevent breast cancer? – New results from a landmark women’s health study raise the exciting possibility that bone-building drugs such as Fosamax and Actonel may help prevent breast cancer. Women who already were using these medicines when the study began were about one-third less likely to develop invasive breast cancer over the next seven years than women not taking such pills, doctors reported Thursday…more
An effort to restrict data mining – An amendment to the Senate health care bill would effectively ban data mining which, as you know, involves the practice of buying prescription records to target sales pitches to doctors, the Associated Press reports. Democrats Herb Kohl of Wisconsin and Dick Durbin of Illinois say their measure will combat “harassing sales practices” and “restrain undue influence” of sales reps…more
Gilead Sciences drug get FDA panel nod – Federal health advisers are recommending the use of an experimental Gilead Sciences drug to treat a form of lung infection. A Food and Drug Administration panel voted 15-2 in favor of the safety and effectiveness of the inhalable drug Cayston. Cayston is intended to treat chronic lung infections in patients with cystic fibrosis — an often fatal disease that affects the lungs and digestive system. Lung infections are the biggest killer of people with the disease. Federal health advisers are recommending the use of an experimental Gilead Sciences drug to treat a form of lung infection…more
King: nice and careful with Embeda promotion.ASH update from Sally Church over at Pharma Strategy blog (Sally is a smart cookie, by the way). Along with her update on how OIG guidelines have impacted the exhibit hall.
RECOMMENDED
On-line: Learning Management; Assessment Management; Simulations; Reinforcements. The Impactiviti network has great suppliers for all your technology training needs – and Impactiviti can provide needed technology consulting for needs analysis, RFP design, and vendor selection. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
PLUS
JUST FOR FUN
———-
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Connect with Steve Woodruff
Leave a Reply